Published in Lancet on January 08, 2000
Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care (2003) 12.01
Which guidelines can we trust?: Assessing strength of evidence behind recommendations for clinical practice. West J Med (2001) 6.10
Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ (2010) 3.80
Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract (2009) 3.70
Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst (2006) 3.31
What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ (2001) 3.15
Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57
Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Med Res Methodol (2001) 2.38
Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual Saf Health Care (2004) 2.28
Evidence-informed health policy 1 - synthesis of findings from a multi-method study of organizations that support the use of research evidence. Implement Sci (2008) 2.15
Critical evaluation of the scientific content in clinical practice guidelines. Cancer (2014) 2.04
Critical evaluation of oncology clinical practice guidelines. J Clin Oncol (2013) 1.78
How does evidence based guidance influence determinations of medical negligence? BMJ (2004) 1.63
How evidence-based are the recommendations in evidence-based guidelines? PLoS Med (2007) 1.60
Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implement Sci (2012) 1.59
Improving the use of research evidence in guideline development: 14. Reporting guidelines. Health Res Policy Syst (2006) 1.51
Differences among international pharyngitis guidelines: not just academic. Ann Fam Med (2007) 1.49
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ (2001) 1.44
Development of evidence-based clinical practice guidelines (CPGs): comparing approaches. Implement Sci (2008) 1.41
Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q (2012) 1.35
Evaluating Guidelines: A Review of Key Quality Criteria. Dtsch Arztebl Int (2015) 1.35
Steps toward massage therapy guidelines: a first report to the profession. Int J Ther Massage Bodywork (2008) 1.34
Guidelines for guidelines: are they up to the task? A comparative assessment of clinical practice guideline development handbooks. PLoS One (2012) 1.29
Categorizing asthma severity: an overview of national guidelines. Clin Med Res (2004) 1.27
Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer (2003) 1.25
Development of practice guidelines. Lancet (2000) 1.19
A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis. Arthritis Res (2001) 1.15
Appraisal tools for clinical practice guidelines: a systematic review. PLoS One (2013) 1.14
Integrating guideline development and implementation: analysis of guideline development manual instructions for generating implementation advice. Implement Sci (2012) 1.14
Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer. BMC Med (2013) 1.12
The limited incorporation of economic analyses in clinical practice guidelines. J Gen Intern Med (2002) 1.10
Involving patients in setting priorities for healthcare improvement: a cluster randomized trial. Implement Sci (2014) 1.07
Quality and methods of developing practice guidelines. BMC Health Serv Res (2002) 1.06
Evidence-informed health policy 2 - survey of organizations that support the use of research evidence. Implement Sci (2008) 1.04
Epilepsy care guidelines for low- and middle- income countries: From WHO mental health GAP to national programs. BMC Med (2012) 1.04
Evaluation of the quality of guidelines for acute gastroenteritis in children with the AGREE instrument. J Pediatr Gastroenterol Nutr (2011) 1.02
Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall. BMC Health Serv Res (2006) 1.01
Canadian Thoracic Society: Presenting a new process for clinical practice guideline production. Can Respir J (2009) 1.00
Is the methodological quality of guidelines declining in the US? Comparison of the quality of US Agency for Health Care Policy and Research (AHCPR) guidelines with those published subsequently. Qual Saf Health Care (2003) 0.99
Clinical practice guidelines within the Southern African Development Community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases. Health Res Policy Syst (2012) 0.98
Guidelines for guideline developers: a systematic review of grading systems for medical tests. Implement Sci (2013) 0.97
European cooperation for clinical practice guidelines in cancer. Br J Cancer (2003) 0.94
Maternal and perinatal guideline development in hospitals in South East Asia: the experience of the SEA-ORCHID project. Health Res Policy Syst (2009) 0.92
Implementing a guideline for the treatment of type 2 diabetics: results of a cluster-randomized controlled trial (C-RCT). BMC Health Serv Res (2007) 0.88
A framework for assessing Health Economic Evaluation (HEE) quality appraisal instruments. BMC Health Serv Res (2012) 0.88
Developing evidence-based clinical practice guidelines in hospitals in Australia, Indonesia, Malaysia, the Philippines and Thailand: values, requirements and barriers. BMC Health Serv Res (2009) 0.87
Current and future relevance of guidelines. Heart (2002) 0.85
Heart disease, guidelines, regulations, and the law. Heart (2002) 0.84
Maternal and perinatal guideline development in hospitals in South East Asia: results from the SEA-ORCHID project. Health Res Policy Syst (2009) 0.84
Heart failure guidelines and prescribing in primary care across Europe. BMC Health Serv Res (2005) 0.83
Guidelines for therapeutic drug monitoring of vancomycin: a systematic review. PLoS One (2014) 0.83
Checklist for standardized reporting of drug-drug interaction management guidelines. Eur J Clin Pharmacol (2013) 0.82
Production and quality of clinical practice guidelines in Argentina (1994-2004): a cross-sectional study. Implement Sci (2008) 0.82
Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer. PLoS One (2014) 0.82
Surgeon-led initiatives cut costs and enhance the quality of endoscopic and laparoscopic procedures. JSLS (2003) 0.80
From rationing to rational: the evolving status of NICE. J R Soc Med (2008) 0.79
Clinical practice guidelines and industry. Mens Sana Monogr (2007) 0.79
Systematic assessment of the quality of osteoporosis guidelines. BMC Musculoskelet Disord (2002) 0.79
Guide to clinical practice guidelines: the current state of play. Int J Qual Health Care (2016) 0.78
Evidence-based practices in mental health: Distant dream or emerging reality? Indian J Psychiatry (2006) 0.77
A critical appraisal of the quality of adult dual-energy X-ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative. Insights Imaging (2017) 0.77
Nondisclosure of Financial Interest in Clinical Practice Guideline Development: An Intractable Problem? PLoS Med (2016) 0.76
Clinical practice guidelines: what they are, why we need them and how they should be developed through rigorous evaluation. Eur J Pediatr (2010) 0.76
[The German nursing expert standards: powerful instruments to improve nursing practice or of doubtful benefit?]. Z Gerontol Geriatr (2006) 0.75
Improving acute medical management: Junior Doctor Emergency Prescription Cards. BMJ Qual Improv Rep (2016) 0.75
Spine radiosurgery for the local treatment of spine metastases: Intensity-modulated radiotherapy, image guidance, clinical aspects and future directions. Clinics (Sao Paulo) (2016) 0.75
The best of 2005 in echocardiography back from EuroEcho 9--Florence, Italy. Cardiovasc Ultrasound (2006) 0.75
Adapting clinical guidelines in low-resources countries: a study on the guideline on the management and prevention of type 2 diabetes mellitus in Indonesia. J Eval Clin Pract (2016) 0.75
Guideline appraisal with AGREE II: Systematic review of the current evidence on how users handle the 2 overall assessments. PLoS One (2017) 0.75
Clinical guidelines: involvement of peers increases physician adherence. World J Gastroenterol (2008) 0.75
Are Guidelines Guiding us on How to Utilize Laboratory Tests? EJIFCC (2015) 0.75
Practice guidelines given by specialty societies. Lancet (2000) 0.75
NICE cancer guidance: a description of the institute's clinical guideline programme. Br J Cancer (2003) 0.75
A patient-centered network approach to multidisciplinary-guideline development: a process evaluation. Implement Sci (2014) 0.75
Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency. PLoS One (2016) 0.75
Credible knowledge: a pilot evaluation of a modified GRADE method using parent-implemented interventions for children with autism. BMC Health Serv Res (2011) 0.75
An evaluation of web-based clinical practice guidelines for managing problems associated with cannabis use. J Med Internet Res (2012) 0.75
Influence of guidelines in determining medical negligence. BMJ (2005) 0.75
Clinical practice guidelines for the foot and ankle in rheumatoid arthritis: a critical appraisal. J Foot Ankle Res (2016) 0.75
Guidelines on chemotherapy in advanced stage gynecological malignancies: an evaluation of 224 professional societies and organizations. PLoS One (2011) 0.75
Medical guidelines and performance measures: the need to keep them free of industry influence. Mens Sana Monogr (2008) 0.75
Data collection of patients with diabetes in family medicine: a study in north-eastern Italy. BMC Health Serv Res (2017) 0.75
Methodological quality of systematic reviews referenced in clinical practice guidelines for the treatment of opioid use disorder. PLoS One (2017) 0.75
A critical appraisal of the quality of adult musculoskeletal ultrasound guidelines using the AGREE II tool: an EuroAIM initiative. Insights Imaging (2017) 0.75
Quality appraisal of clinical practice guidelines on glioma. Neurosurg Rev (2014) 0.75
Which guidelines can we trust?: Assessing strength of evidence behind recommendations for clinical practice. West J Med (2001) 6.10
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (1994) 4.42
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65
Consumer participation in research and health care. BMJ (1997) 3.38
What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol (1990) 3.31
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17
A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest (1998) 2.97
HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A (1991) 2.83
The Italian way of osteoporosis. Lancet (1992) 2.67
Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package. JAMA (1995) 2.62
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology (1997) 2.61
Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol (1993) 2.44
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med (1994) 2.18
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18
Quality of systematic reviews used in guidelines for oncology practice. Ann Oncol (2006) 2.15
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest (1991) 2.08
T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology (1994) 2.00
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology (2001) 1.99
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98
Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol (1987) 1.85
Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol (1993) 1.74
A European version of the Appropriateness Evaluation Protocol. Goals and presentation. The BIOMED I Group on Appropriateness of Hospital Use. Int J Technol Assess Health Care (1999) 1.73
Short stay facilities: the future of efficient paediatric emergency services. Arch Dis Child (1996) 1.64
The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care (1991) 1.62
Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59
Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51
Essential requirements for practice guidelines at national and local levels. Neurol Sci (2004) 1.49
A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46
The risk of bias from omitted research. BMJ (2000) 1.43
Drug use during pregnancy. Lancet (2001) 1.43
Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol (1998) 1.43
The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. Eur Heart J (2001) 1.41
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol (1987) 1.25
Promoting consumers' demand for evidence-based medicine. Int J Technol Assess Health Care (1998) 1.24
Practice guidelines: useful and "participative" method? Survey of Italian physicians by professional setting. Arch Intern Med (2001) 1.22
Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol (1986) 1.14
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2000) 1.13
Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance. Ann Oncol (2010) 1.09
Cellular immune response to hepatitis B virus antigens. An overview. J Hepatol (1988) 1.05
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology (1997) 1.04
Appropriateness of hospital use: an overview of Italian studies. Int J Qual Health Care (1995) 1.03
The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest (1989) 1.02
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology (2001) 0.99
Psychological outcomes in women with early breast cancer. BMJ (1990) 0.99
Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders. Clin Pract Epidemiol Ment Health (2012) 0.97
Risk factors for pathologically confirmed benign breast disease. Am J Epidemiol (1984) 0.97
Parasitic diatoms inside antarctic sponges. Biol Bull (2000) 0.97
Immunopathogenesis of hepatitis C virus infection. J Hepatol (1999) 0.97
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth (2010) 0.96
Social factors, diet and breast cancer in a northern Italian population. Br J Cancer (1984) 0.96
Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst (1982) 0.96
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. Gastroenterology (1992) 0.95
Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users. Neurol Sci (2002) 0.93
Gonadotropin-releasing hormone action in the pituitary: a three step mechanism. Endocr Rev (1981) 0.93
Performance evaluation of paediatric propofol pharmacokinetic models in healthy young children. Br J Anaesth (2011) 0.93
Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat (1999) 0.92
Patients' assessment of quality of care: a survey of a group of breast cancer patients in Italy. Tumori (1985) 0.92
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections. Recent Results Cancer Res (1998) 0.92
Prescription of opioids in Italy: everything, but the morphine. Ann Oncol (2009) 0.90
Truth telling: a cultural or individual choice? JAMA (1993) 0.90
Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials. JAMA (1986) 0.90
The clinical relevance of the epidemiology of ovarian cancer. Eur J Cancer Clin Oncol (1984) 0.89
MtDNA polymorphisms in a sample of Czechoslovaks and in two groups of Italians. Gene Geogr (1994) 0.89
Lung cancer care in general hospitals. Tumori (1983) 0.89
FARMAGUIDA: a databank for the analysis of the Italian drug market and drug utilization in general practice. Eur J Clin Pharmacol (1992) 0.89
Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trials. Eur Psychiatry (1996) 0.89
Interferon treatment in patients with chronic hepatitis B: a meta-analysis of the published literature. J Hepatol (1993) 0.86
Sensory stimulation for brain injured individuals in coma or vegetative state. Cochrane Database Syst Rev (2002) 0.86
Autopresentation of hepatitis B virus envelope antigens by T cells. J Virol (1992) 0.86
Beware of surrogate outcome measures. Int J Technol Assess Health Care (1996) 0.85
Detection and quantification of Prymnesium parvum (Haptophyceae) by real-time PCR. Lett Appl Microbiol (2007) 0.84
Care of cancer patients in thirty-one Italian general hospitals. Methodological aspects and general findings. Eur J Cancer Clin Oncol (1983) 0.83
GPs' satisfaction with the doctor-patient encounter: findings from a community-based survey. Fam Pract (2003) 0.83
Inappropriate Halsted mastectomy and patient volume in Italian hospitals. Am J Public Health (1993) 0.83
Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence. Eur Rev Med Pharmacol Sci (2013) 0.83
Quality of breast-cancer care in Italian general hospitals. Lancet (1982) 0.82
Audit of a shared-care program for persons with diabetes: baseline and 3 annual follow-ups. Acta Diabetol (2004) 0.81
The influence of patient characteristics on the appropriateness of surgical treatment for breast cancer patients. Progetto Oncologia Femminile. Ann Oncol (1993) 0.81
Quality of life among mastectomy patients using external breast prostheses. Tumori (1997) 0.81
Physicians' view of practice guidelines. A survey of Italian physicians. Soc Sci Med (1996) 0.81
The Di Bella multitherapy trial. Randomised controlled trials may not always be absolutely needed. BMJ (1999) 0.81
Genetic testing is ready to change the diagnostic scenario of lactose malabsorption. Gut (2008) 0.80
Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages. Immunopharmacol Immunotoxicol (2005) 0.80
New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease. Immunopharmacol Immunotoxicol (2006) 0.80